Merck KGaA (MRK.DE) XETRA

Currency In EUR

AD

Merck KGaA

Address

Frankfurter Strasse 250

Darmstadt, 64293

Germany

Phone

49 6151 72 0

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

59020

First IPO Date

June 26, 1998

Key Executives

NameTitlePayYear Born
Jean Charles WirthMember of the Executive Board & Chief Executive Officer Life Science1.21M1973
Danny Pinhas Bar-ZoharMember of the Executive Board & Chief Executive Officer of Healthcare1.22M1970
Kai BeckmannCEO & Chair of Management Board4.93M1965
Benjamin HeinMember of Management Board & CEO of Electronics Business Sector0N/A
Khadija Ben HammadaMember of the Executive Board & Chief People Officer1.21M1980
Helene von RoederChief Financial Officer & Member of Executive Board4.76M1970
Belen Garijo LopezExecutive Officer6.71M1960
Florian SchraederHead of Investor Relations0N/A
Axel LoberHead of Global Communications0N/A
Marc HornHead of Life Science Controlling01975
Frank GotthardtHead of Corporate & Government Relations - Europe0N/A
AD

Description

Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research institutions, biotechnology firms, pharmaceutical manufacturers, and various industrial sectors. It also offers specialized process development expertise, such as continuous bioprocessing for drug manufacturers, provides a range of testing kits, reagents, and services, and develops solutions for analyzing environmental samples like air, water, and soil. Furthermore, this segment aids in assessing nutritional value and identifying quality control issues. In its Healthcare segment, the company is involved in the entire lifecycle of prescription drugs and biopharmaceuticals, from initial discovery and development through manufacturing and marketing. Its therapeutic focus areas include oncology, neurology and immunology, fertility, endocrinology, cardiovascular diseases, diabetes, thyroid disorders, and multiple sclerosis. This segment also produces general medicines, injection devices, and software for disease monitoring. The Electronics division delivers critical materials for the semiconductor and display industries. It also specializes in surface design, providing delivery systems and services, along with a variety of surface solutions for applications such as cosmetics, effect pigments, and other functional materials. Merck KGaA is also actively engaged in strategic partnerships. These include in-licensing agreements with Debiopharm International SA for developing treatments for head and neck cancer, with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for metastatic colorectal cancer drug candidates, and with Abbisko Therapeutics Co. Ltd. for therapies targeting tenosynovial giant cell tumors. Additionally, the company is involved in collaborations focused on discovering and developing targeted protein degraders against critical oncogenic proteins. Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA operates as a subsidiary of E. Merck KG.

AD